Product Description
Since Last many years Saintroy Lifescience is leading manufacture, export and supplier of Arteether + Lumefantrine Tablets from Surat, Gujarat, India. Artemether Lumefantrine Tablets used to treat malaria caused by Plasmodium falciparum that is not treatable with chloroquine. It is not typically used to prevent malaria.
Tags: Artemether + Lumefantrine Tablets manufacturer , Arteether + LumefantrineTablets exporter, Arteether + Lumefantrine Tablets supplier, and Artemether + Lumefantrine Tablets ,whogmp approved Artemether + Lumefantrine Tablets manufacturer and supplier, Arteether + Lumefantrine Tablets distributor, Arteether + Lumefantrine Tablets dropshipper, Arteether + LumefantrineTablets 80 mg, Arteether + Lumefantrine Tablets 80 mg supplier, Arteether + Lumefantrine Tablets 80 mg.
ISO/GMP/cGMP/WHOGMP/NAFDACapproved, PPB Kenya approved/USFDA approved/EUGMP approved/MOH Iran approved manufacturing facility in Gujarat, India.
Registration: Saintroy Lifescience is interested in registration of own brand or customer brands in ministry of health of clients country and we also provide the products samples,COA, COPP, ACTD or CTD Dossier, DMF, Manufacturing license, Free sales certificate and other required documents.
Export Country :Saintroy Lifescience Artemether + Lumefantrine Tablets export toUSA, Canada, Germany, Europe, France, Ghana, Nigeria, Kenya, Senegal,Sudan,UAE, Kuwait, Dubai, Cameroon, Lebanon, Peru, Chile, Somalia,Philippines,Myanmar, Maldives, Thailand, Singapore, Malaysia, Hong Kong, China,Zimbabwe,Togo, Burkina Faso, Niger, Guinea Bissau, Congo, Democratic of republic, Ivory Costa, Oman, Guatemala, Nicaragua, Salvador, Qatar, Costa Rica,Panama, Cuba,Colombia, Bolivia, Argentine, Algeria, Guyana, Morocco, Jordan,Bahrain, Iran, Egypt, Kyrgyzstan, Uzbekistan, Kazakhstan.
Potent Malaria DefenseArteether + Lumefantrine Tablets offer robust protection and treatment against malaria, particularly in regions where resistance to other antimalarial drugs has emerged. With a carefully balanced combination of two active ingredients, they target malaria parasites effectively and are suitable for use in various adult age groups.
Convenient and Safe UsageThese tablets come in a physical tablet form, simplifying administration and adherence to a prescribed regimen. Suitable for women, adults, and the elderly, Arteether + Lumefantrine tablets can be easily incorporated into daily routines, ensuring continual protection with physician supervision.
FAQ's of Arteether + Lumefantrine Tablets:
Q: How do Arteether + Lumefantrine Tablets work to treat malaria?
A: Arteether and Lumefantrine act synergistically by targeting different stages of the malaria parasite's lifecycle. Together, they effectively reduce the parasite load, thus providing rapid relief from symptoms and lowering the risk of complications.
Q: What is the recommended process for taking these tablets?
A: Take Arteether + Lumefantrine Tablets strictly as directed by your physician. Never self-adjust the dosage or duration, as professional guidance is crucial for both efficacy and safety in treating malaria.
Q: When should I start taking Arteether + Lumefantrine Tablets for malaria?
A: Begin taking the medication as soon as your doctor diagnoses malaria. Early initiation of treatment ensures higher effectiveness and helps prevent severe progression of the disease.
Q: Where should Arteether + Lumefantrine Tablets be stored?
A: These tablets should be kept in a cool, dry place, away from direct sunlight and moisture. Always follow storage guidelines provided by your physician to maintain medication quality.
Q: Who can benefit from using Arteether + Lumefantrine Tablets?
A: This medication is suitable for adult women, men, and aged persons under medical supervision. It is especially beneficial for individuals residing in or traveling to malaria-prone areas.
Q: What precautions should be taken while using these tablets?
A: Always adhere to your doctor's dosage instructions and inform them of your medical history and any other medications you are taking to avoid adverse interactions.